Biotech | March 09, 2022
Alvotech settles with AbbVie to secure US rights to Humira biosimilar
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023
Price was the key driver for the period
Toyobo will start looking at ways to use the knowhow from DMC’s sophisticated fermentation process technologies to enhance the efficiency of making its bioproducts
Alongside brand refresh, the leading clinical trial technology company announces eConsent and eCOA offerings to better support the patient clinical trial journey
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
Subscribe To Our Newsletter & Stay Updated
